233 related articles for article (PubMed ID: 29415171)
1. Osteoglycin attenuates cardiac fibrosis by suppressing cardiac myofibroblast proliferation and migration through antagonizing lysophosphatidic acid 3/matrix metalloproteinase 2/epidermal growth factor receptor signalling.
Zuo C; Li X; Huang J; Chen D; Ji K; Yang Y; Xu T; Zhu D; Yan C; Gao P
Cardiovasc Res; 2018 Apr; 114(5):703-712. PubMed ID: 29415171
[TBL] [Abstract][Full Text] [Related]
2. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway.
Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ
Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703
[TBL] [Abstract][Full Text] [Related]
3. Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis.
Wu MP; Zhang YS; Xu X; Zhou Q; Li JD; Yan C
Cardiovasc Drugs Ther; 2017 Apr; 31(2):157-166. PubMed ID: 28321644
[TBL] [Abstract][Full Text] [Related]
4. Regulation of MT1-MMP and MMP-2 by leptin in cardiac fibroblasts involves Rho/ROCK-dependent actin cytoskeletal reorganization and leads to enhanced cell migration.
Schram K; Ganguly R; No EK; Fang X; Thong FS; Sweeney G
Endocrinology; 2011 May; 152(5):2037-47. PubMed ID: 21385940
[TBL] [Abstract][Full Text] [Related]
5. DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
Zhai CG; Xu YY; Tie YY; Zhang Y; Chen WQ; Ji XP; Mao Y; Qiao L; Cheng J; Xu QB; Zhang C
J Mol Cell Cardiol; 2018 Jan; 114():243-252. PubMed ID: 29196099
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK.
Siddesha JM; Valente AJ; Sakamuri SS; Yoshida T; Gardner JD; Somanna N; Takahashi C; Noda M; Chandrasekar B
J Mol Cell Cardiol; 2013 Dec; 65():9-18. PubMed ID: 24095877
[TBL] [Abstract][Full Text] [Related]
7. CD1d-dependent natural killer T cells attenuate angiotensin II-induced cardiac remodelling via IL-10 signalling in mice.
Wang HX; Li WJ; Hou CL; Lai S; Zhang YL; Tian C; Yang H; Du J; Li HH
Cardiovasc Res; 2019 Jan; 115(1):83-93. PubMed ID: 29939225
[TBL] [Abstract][Full Text] [Related]
8. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways.
Rupérez M; Rodrigues-Díez R; Blanco-Colio LM; Sánchez-López E; Rodríguez-Vita J; Esteban V; Carvajal G; Plaza JJ; Egido J; Ruiz-Ortega M
Hypertension; 2007 Aug; 50(2):377-83. PubMed ID: 17592071
[TBL] [Abstract][Full Text] [Related]
9. Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway.
Tsai SH; Huang PH; Peng YJ; Chang WC; Tsai HY; Leu HB; Chen JW; Lin SJ
Cardiovasc Res; 2013 Dec; 100(3):501-10. PubMed ID: 24225494
[TBL] [Abstract][Full Text] [Related]
10. Small GTP-binding protein, Rho, both increased and decreased cellular motility, activation of matrix metalloproteinase 2 and invasion of human osteosarcoma cells.
Matsumoto Y; Tanaka K; Harimaya K; Nakatani F; Matsuda S; Iwamoto Y
Jpn J Cancer Res; 2001 Apr; 92(4):429-38. PubMed ID: 11346466
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
12. Air pollution and cardiac remodeling: a role for RhoA/Rho-kinase.
Ying Z; Yue P; Xu X; Zhong M; Sun Q; Mikolaj M; Wang A; Brook RD; Chen LC; Rajagopalan S
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1540-50. PubMed ID: 19286943
[TBL] [Abstract][Full Text] [Related]
13. ADAMTS16 activates latent TGF-β, accentuating fibrosis and dysfunction of the pressure-overloaded heart.
Yao Y; Hu C; Song Q; Li Y; Da X; Yu Y; Li H; Clark IM; Chen Q; Wang QK
Cardiovasc Res; 2020 Apr; 116(5):956-969. PubMed ID: 31297506
[TBL] [Abstract][Full Text] [Related]
14. Loss of PI3Kγ enhances cAMP-dependent MMP remodeling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress.
Guo D; Kassiri Z; Basu R; Chow FL; Kandalam V; Damilano F; Liang W; Izumo S; Hirsch E; Penninger JM; Backx PH; Oudit GY
Circ Res; 2010 Nov; 107(10):1275-89. PubMed ID: 20847309
[TBL] [Abstract][Full Text] [Related]
15. Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction.
Fan D; Takawale A; Basu R; Patel V; Lee J; Kandalam V; Wang X; Oudit GY; Kassiri Z
Cardiovasc Res; 2014 Jul; 103(2):268-80. PubMed ID: 24692173
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction.
Ainscough JF; Drinkhill MJ; Sedo A; Turner NA; Brooke DA; Balmforth AJ; Ball SG
Cardiovasc Res; 2009 Feb; 81(3):592-600. PubMed ID: 18703536
[TBL] [Abstract][Full Text] [Related]
17. Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway.
Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
J Exp Clin Cancer Res; 2018 Mar; 37(1):41. PubMed ID: 29499765
[TBL] [Abstract][Full Text] [Related]
18. TRIF/EGFR signalling mediates angiotensin-II-induced cardiac remodelling in mice.
Zhu H; Cao W; Zhao P; Wang J; Qian Y; Li Y
J Mol Endocrinol; 2020 Aug; 65(2):11-20. PubMed ID: 32580159
[TBL] [Abstract][Full Text] [Related]
19. Ginseng (Panax quinquefolius) attenuates leptin-induced cardiac hypertrophy through inhibition of p115Rho guanine nucleotide exchange factor-RhoA/Rho-associated, coiled-coil containing protein kinase-dependent mitogen-activated protein kinase pathway activation.
Moey M; Rajapurohitam V; Zeidan A; Karmazyn M
J Pharmacol Exp Ther; 2011 Dec; 339(3):746-56. PubMed ID: 21875949
[TBL] [Abstract][Full Text] [Related]
20. Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice.
Liu Y; Gao L; Guo S; Liu Y; Zhao X; Li R; Yan X; Li Y; Wang S; Niu X; Yao L; Zhang Y; Li L; Yang H
Cell Physiol Biochem; 2017; 43(6):2253-2263. PubMed ID: 29073623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
